Search for: "Pharmaceutical Associates, Inc." Results 61 - 80 of 1,899
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2022, 2:59 pm by Kevin LaCroix
The authors of this guest post are: Doug Greene, BakerHostetler, Leader, Securities and Governance Litigation Team; Genevieve York-Erwin, BakerHostetler, Partner; Mike Tomasulo, Baldwin Risk Partners, Managing Partner, Management Liability National Practice Leader: Emily Baxter,  BakerHostetler, Associate; and Alex Karambelas, BakerHostetler, Associate. [read post]
30 Jun 2022, 4:02 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
27 Jun 2022, 9:01 pm by Paul Hodgson
Of those, just two received majority support, at Netflix and The Travelers Companies, Inc. [read post]
19 Jun 2022, 5:05 pm by admin
Professor Mayo’s recent article explores the interesting concept of intellectual conflicts of interest arising from journal editors and association leaders who use their positions to advance their personal views. [read post]
17 Jun 2022, 2:09 pm by admin
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
25 May 2022, 2:26 am by Matrix Legal Support Service
The Appellants are both pharmaceutical companies fined by the CMA and both appealed to the Competition Appeal Tribunal (CAT) challenging the CMA’s decision. [read post]
24 May 2022, 4:23 pm by Bill Marler
Again, FDA tested product associated with this illness, found no Cronobacter, and notified Abbott Nutrition. [read post]
23 May 2022, 8:02 am by admin
Kelly and two of his former associates go on trial in Chicago, the sparks are starting to fly. [read post]
8 Apr 2022, 2:05 am by Editors
(Boston, MA) Commercial Counsel, Wayfair Inc. [read post]
29 Mar 2022, 5:04 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
24 Mar 2022, 12:04 pm by Zak Gowen
District Court for the Eastern District of California granted the motion of a trade association of pharmaceutical manufacturers—the Association for Accessible Medicines’ (“AAM”)—to enjoin AB 824 on the grounds that it likely violated the U.S. [read post]
19 Mar 2022, 2:09 pm by admin
Thus, cancer risk of a continuous low dose over a lifetime would be equivalent to the cancer risk associated with an identical cumulative exposure averaged over a shorter duration. [read post]
13 Mar 2022, 9:44 am by Kevin LaCroix
On November 6, 2020, KBL entered a business combination with 180 Life Sciences Corp, Katexco Pharmaceuticals Corp., and CannBioRx. [read post]
9 Mar 2022, 7:47 pm by Cynthia Marcotte Stamer
Public companies and other market participating or influencing companies and their leaders should begin preparing to comply with enhanced cybersecurity risk management, disclosure, strategy, governance and incident reporting and response requirements of a Proposed Rule the Security and Exchange Commission (“SEC”) published in today’s (March 9, 2022) Federal Register. [read post]
26 Feb 2022, 6:53 pm by admin
Although the Taskforce did not elaborate, it advanced five basic propositions, which had been obscured by many of the recent glosses on the ASA 2016 p-value statement, and the 2019 editorial discussed above: “Capturing the uncertainty associated with statistical summaries is critical. [read post]